This trial studies the screening of human papillomavirus (HPV)-related oropharyngeal and
anogenital cancers. Learning the relationship between HPV and cancer risk in men who test
positive for HPV antibodies or circulating HPV DNA may help doctors to develop early methods
of screening for certain types of cancer, and screening for HPV may help doctors to learn
which patients may be at a higher risk for developing certain types of cancer.